Low hematocrit reduces the efficiency of CD34 + cell collection when using the Spectra Optia continuous mononuclear cell collection procedure.

Takumi Kondo Nobuharu FujiiKeiko FujiiYuichi SumiiTomohiro UrataMaiko KimuraMasayuki MatsudaShuntaro IkegawaKana WashioHideaki FujiwaraNoboru AsadaDaisuke EnnishiHisakazu NishimoriKen-Ichi MatsuokaFumio OtsukaYoshinobu Maeda

Published in: Transfusion (2022)

cell collection when using the Optia cMNC protocol and suggest that hematocrit values should also be considered when determining PBV.

Keyphrases

single cell
cell therapy
randomized controlled trial
stem cells
minimally invasive
bone marrow